SciELO - Scientific Electronic Library Online

 
vol.17 número32Plantão Psicológico como estratégia de cuidado no Centro de Atenção Psicossocial: desafios e possibilidadesEstratégias de prevenção e promoção à saúde mental para policiais: uma revisão de escopo índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados

Journal

artigo

Indicadores

Compartilhar


Mental

versão impressa ISSN 1679-4427versão On-line ISSN 1984-980X

Resumo

SOUSA, Amanda Gomes Teixeira de; GIROLDI, Maria Laura de Carvalho; NUNES, Ricardo Ferreira  e  FERES, Daniel Dias Santos. Use of cannabidiol in the signs and comorbidities in children with Autism Spectrum Disorder: An integrative review. Mental [online]. 2025, vol.17, n.32, pp.72-81.  Epub 10-Nov-2025. ISSN 1679-4427.  https://doi.org/10.5935/1679-4427.v17n32.0008.

Autism Spectrum Disorder (ASD) is a neurodevelopmental disorder characterized by deficits in communication and social interaction, as well as repetitive behavior patterns. Cannabidiol (CBD) has emerged as a therapeutic alternative due to the side effects of traditional treatments. This study aims to review clinical studies on the use of CBD in ASD, evaluating its benefits and side effects. To this end, publications were searched in Medline and PubMed using the descriptors: autism, cannabidiol, child, treatment. The results indicate that CBD has shown benefits, including a reduction in hyperactivity, self-injury, and temper outbursts, with mild and manageable side effects. It is concluded that CBD use has led to improvements in ASD symptoms, but further large-scale clinical trials are necessary to confirm its effectiveness.

Palavras-chave : Autism; cannabidiol; child; treatment.

        · resumo em Português | Espanhol     · texto em Português     · Português ( pdf )